Navigation Links
Veteran Intellectual Property Team Joins Brown Rudnick

Attorneys practice in pharma, biotech, medical device, and software industries, among others

Boston, Massachusetts (Vocus) -- Brown Rudnick, an international law firm, today announced that a veteran Intellectual Property ("IP") team from Cooley Godward Kronish LLP has joined the Firm's Boston office. With over 35 years of combined experience, the team includes Partners Thomas C. Meyers and Robert J. Tosti.

Mr. Meyers has over 18 years of experience creating and implementing patent strategies for biotechnology, medical device, and pharmaceutical companies. He routinely advises life science companies, startups, venture capital firms, investment banks and academic institutions; and has negotiated and drafted numerous multimillion dollar collaborations. Previously, Mr. Meyers was a partner at Testa, Hurwitz & Thibeault, LLP and later was Vice President and General Counsel at Helicos BioSciences Corporation.

Mr. Tosti is experienced in all areas of IP law including patent and trademark counseling, opinions, and prosecution, IP portfolio development, licensing, litigation, and the assessment and enforcement of IP rights. He is a registered patent attorney with a background in electrical engineering and represents clients across a variety of technologies including software, business methods, electronics, and medical devices.

According to Brown Rudnick CEO Joseph F. Ryan, "Tom and Rob bring significant breadth and depth of IP experience, particularly in the pharma, biotech, medical device and software sectors. Their addition strengthens our IP Group's platform in these important markets and demonstrates the Firm's commitment to advising global clients on how to best manage and safeguard their intellectual property rights."

This notice follows the recent announcement that a highly respected and successful litigation team joined the Firm's London office on July 6, 2009. The group is led by partner Neil Micklethwaite who is joined by a senior associate and two trainees scheduled to qualify later this year. Neil is one of the former principals of Gherson, a litigation boutique in the U.K. He has been practicing law for 25 years, and was previously head of litigation in London for both Bingham McCutchen and DLA Piper.

In addition, Brown Rudnick recently added Corporate Partner, Lena Hodge, and Tax Partner, Tracy Fisher, to the Firm's London office.

About Brown Rudnick LLP
Brown Rudnick is an international law firm with offices in the United States and Europe. The firm represents clients from around the world, providing business-focused solutions that address today's ever-changing, ever-demanding competitive marketplace. With an entrepreneurial and collaborative mindset, Brown Rudnick offers a broad slate of capabilities and talents in areas that include: Corporate, Intellectual Property, Emerging Technologies, Tax Law, Finance, Bankruptcy & Corporate Restructuring, Real Estate, Complex Litigation, Government Law & Strategies, Government Contracts, Energy, Cleantech and Health Law. For more information, please visit

The Brown Rudnick Center for the Public Interest is a measure of the Firm's strong commitment to the community and serves as an umbrella entity encompassing the Firm's pro bono legal work, charitable giving, community involvement and public interest efforts. For more information, please visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
2. IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors
3. Former Secretary of Veterans Affairs James Peake to Join the Cellphire Board of Directors
4. Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents
5. Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
6. Veteran-Owned Biotech Startup Company Charges Health Agency (NYSDOH) with Blackballing its Initiatives
7. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
8. Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company
9. Video: Turning Hope Into Reality - VA Research to Restore Veterans Abilities
10. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
11. Energy, Biotechnology and Agribusiness Veterans Form SG Biofuels to Develop Jatropha as Low-Cost, Sustainable Oil
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... HART ), a biotechnology company developing bioengineered organ implants ... McGorry will present at the LD Micro "Main ... 2:30 p.m. PT. The presentation will be webcast live ... Management will also be available at the conference for ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
Breaking Biology Technology:
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
(Date:10/27/2015)... Oct. 27, 2015 In the present market ... concern for various industry verticals such as banking, healthcare, ... the growing demand for secure & simplified access control ... such as hacking of bank accounts, misuse of users, ... such as PC,s, laptops, and smartphones are expected to ...
Breaking Biology News(10 mins):